Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Vet Res ; 47: 44, 2016 Mar 17.
Artigo em Inglês | MEDLINE | ID: mdl-26987959

RESUMO

ß-defensins are an important element of the mucosal innate immune response against bacterial pathogens. Tracheal antimicrobial peptide (TAP) has microbicidal activity against the bacteria that cause bovine respiratory disease, and its expression in tracheal epithelial cells is upregulated by bacterial products including lipopolysaccharide (LPS, a TLR4 agonist), Pam3CSK4 (an agonist of Toll-like receptor 2/1), and interleukin (IL)-17A. The objectives of this study were to identify the signalling pathway by which LPS, Pam3CSK4 and IL-17A induce TAP gene expression, and to determine the effect of glucocorticoid as a model of stress on this epithelial innate immune response. In primary cultures of bovine tracheal epithelial cells (bTEC), LPS, Pam3CSK4 and IL-17A each stimulated TAP gene expression. This effect was abrogated by caffeic acid phenylester (CAPE), an inhibitor of NF-κB. Similarly, western analysis showed that LPS, Pam3CSK4 and IL-17A each induced translocation of NF-κB p65 from the cytoplasm to the nucleus, but pre-treatment with CAPE inhibited this response. Finally, pre-treatment of bTEC with the glucocorticoid dexamethasone abolished the stimulatory effect of LPS, Pam3CSK4 and IL-17A on upregulation of TAP gene expression. These findings indicate that NF-κB activation is necessary for induction of TAP gene expression by LPS (a TLR4 agonist), Pam3CSK4 (a TLR2/1 agonist), or IL-17A. Furthermore, this stimulatory response is inhibited by glucocorticoid, suggesting this as one mechanism by which stress increases the risk of bacterial pneumonia. These findings have implications for understanding the pathogenesis of stress-associated bacterial pneumonia, and for developing methods to stimulate innate immune responses in the respiratory tract of cattle.


Assuntos
Peptídeos Catiônicos Antimicrobianos/genética , Dexametasona/farmacologia , Células Epiteliais/efeitos dos fármacos , Lipopolissacarídeos/farmacologia , Traqueia/efeitos dos fármacos , Regulação para Cima , Animais , Peptídeos Catiônicos Antimicrobianos/metabolismo , Bovinos , Células Epiteliais/metabolismo , Células Epiteliais/patologia , Glucocorticoides/farmacologia , Interleucina-17/farmacologia , Lipopeptídeos/farmacologia , Traqueia/citologia , Traqueia/metabolismo
2.
Vet Res ; 45: 105, 2014 Oct 12.
Artigo em Inglês | MEDLINE | ID: mdl-25304258

RESUMO

Bovine respiratory disease is a complex of bacterial and viral infections of economic and welfare importance to the beef industry. Although tracheal antimicrobial peptide (TAP) has microbicidal activity against bacterial pathogens causing bovine respiratory disease, risk factors for bovine respiratory disease including BVDV and stress (glucocorticoids) have been shown to inhibit the induced expression of this gene. Lipopolysaccharide is known to stimulate TAP gene expression, but the maximum effect is only observed after 16 h of stimulation. The present study investigated other agonists of TAP gene expression in primary cultures of bovine tracheal epithelial cells. PCR analysis of unstimulated tracheal epithelial cells, tracheal tissue and lung tissue each showed mRNA expression for Toll-like receptors (TLRs) 1-10. Quantitative RT-PCR analysis showed that Pam3CSK4 (an agonist of TLR1/2) and interleukin (IL)-17A significantly induced TAP gene expression in tracheal epithelial cells after only 4-8 h of stimulation. Flagellin (a TLR5 agonist), lipopolysaccharide and interferon-α also had stimulatory effects, but little or no response was found with class B CpG ODN 2007 (TLR9 agonist) or lipoteichoic acid (TLR2 agonist). The use of combined agonists had little or no enhancing effect above that of single agonists. Thus, Pam3CSK4, IL-17A and lipopolysaccharide rapidly and significantly induce TAP gene expression, suggesting that these stimulatory pathways may be of value for enhancing innate immunity in feedlot cattle at times of susceptibility to disease.


Assuntos
Peptídeos Catiônicos Antimicrobianos/genética , Doenças dos Bovinos/imunologia , Células Epiteliais/efeitos dos fármacos , Células Epiteliais/imunologia , Regulação da Expressão Gênica/efeitos dos fármacos , Receptores Toll-Like/genética , Animais , Anti-Infecciosos/metabolismo , Anti-Infecciosos/farmacologia , Bovinos , Células Epiteliais/microbiologia , Imunidade nas Mucosas/efeitos dos fármacos , Ligantes , Lipopolissacarídeos/farmacologia , Receptores Toll-Like/agonistas , Receptores Toll-Like/metabolismo , Traqueia/efeitos dos fármacos , Traqueia/imunologia , Traqueia/microbiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA